Back to Search
DWIGHT CHIEN, L.AC., D.AC., PH.D.
L.AC., D.AC., PH.D.
Acupuncturist
NPI: 1598138927Individual
Specialties, Licenses & Credentials
AcupuncturistPrimary
Acupuncturist
Code: 171100000X
25MZ00115000(NJ)
Research & Publications (20)
Ubiquitin-independent degradation of hepatitis C virus F protein.
PMID 18971267·J Virol·2009
7-preclinical
Solanum erianthum intoxication mimicking an acute cerebrovascular disease.
PMID 19371544·Am J Emerg Med·2009
5-case
Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin.
PMID 19155517·J Immunol·2009
8-other
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.
PMID 18508900·J Virol·2008
7-preclinical
Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors.
PMID 18382014·Hong Kong Med J·2008
8-other
CD4(+) (and not CD25+) T cells are the predominant interleukin-10-producing cells in the circulation of filaria-infected patients.
PMID 18171291·J Infect Dis·2008
7-preclinical
Induction of TRAIL- and TNF-alpha-dependent apoptosis in human monocyte-derived dendritic cells by microfilariae of Brugia malayi.
PMID 18981128·J Immunol·2008
7-preclinical
Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist.
PMID 18753409·J Pharmacol Exp Ther·2008
7-preclinical
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.
PMID 17919789·Vaccine·2007
7-preclinical
Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
PMID 17601775·Proc Natl Acad Sci U S A·2007
4-observational
Development and validation of a stability-indicating reversed-phase high performance liquid chromatography method for assay of betamethylepoxide and estimation of its related compounds.
PMID 17512937·J Chromatogr A·2007
4-observational
Antibodies to a novel antigen in acute hepatitis C virus infections.
PMID 17181584·Vox Sang·2007
8-other
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
PMID 16847121·J Gen Virol·2006
7-preclinical
Rapid assessment of left ventricular segmental wall motion, ejection fraction, and volumes with single breath-hold, multi-slice TrueFISP MR imaging.
PMID 16755829·J Cardiovasc Magn Reson·2006
8-other
California ground squirrel (Spermophilus beecheyi) defenses against rattlesnake venom digestive and hemostatic toxins.
PMID 16525875·J Chem Ecol·2006
7-preclinical
Direct quantitative in vivo comparison of calcified atherosclerotic plaque on vascular MRI and CT by multimodality image registration.
PMID 16463307·J Magn Reson Imaging·2006
4-observational
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.
PMID 15824985·Clin Infect Dis·2005
8-other
California ground squirrel (Spermophilus beecheyi) defenses against rattlesnake venom digestive and hemostatic toxins.
PMID 16273425·J Chem Ecol·2005
7-preclinical
Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.
PMID 16081931·J Clin Microbiol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1146 RARITAN RD
CLARK, NJ 07066 - Phone
- (917) 514-0997
Quick Facts
- NPI
- 1598138927
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile